Marksans Pharma consolidated net profit rises 26.80% in the June 2021 quarter
Sales rise 5.38% to Rs 348.96 crore
Net profit of Marksans Pharma rose 26.80% to Rs 62.60 crore in the quarter ended June 2021 as against Rs 49.37 crore during the previous quarter ended June 2020. Sales rose 5.38% to Rs 348.96 crore in the quarter ended June 2021 as against Rs 331.15 crore during the previous quarter ended June 2020. ParticularsQuarter EndedJun. 2021Jun. 2020% Var.Sales348.96331.15 5 OPM %22.1621.14 -PBDT82.2668.65 20 PBT74.7861.40 22 NP62.6049.37 27Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 11 2021 | 5:29 PM IST